Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of the exchange of non-public exchangeable corporate bonds issued by the company's second largest shareholder and the equity change ratio due to the exchange

SZSI · Jun 30, 2021 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

双鹭药业：北京双鹭药业股份有限公司关于公司第二大股东非公开发行可交换公司债券换股进展暨换股导致权益变动比例超过1%的公告

Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of the exchange of non-public exchangeable corporate bonds issued by the company's second largest shareholder and the equity change ratio due to the exchange

Risk Disclaimer

Statement